May 11, 2018 Cellectar Reports Recent Corporate Highlights and 2018 First Quarter Financial Results Learn More
May 9, 2018 Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma Learn More
May 2, 2018 Cellectar Receives Rare Pediatric Disease Designation for CLR 131 to Treat Neuroblastoma Learn More
Apr 17, 2018 Cellectar Presents Preclinical Data at AACR Annual Meeting Demonstrating Efficacy of Fractionated Injections of CLR 131 in Multiple Myeloma Learn More